Filing Flows › Tonix Pharmaceuticals Holding (TNXP) › Tonmya revenue
Tonix Pharmaceuticals Holding (TNXP) Tonmya revenue by quarter
Tonix Pharmaceuticals Holding's Tonmya revenue was $15.0M in Q3 2026 (third quarter 2026), +37% from Q2 2026. Over the last 3 quarters it ranged from $3.7M (Q1 2026) to $15.0M (Q3 2026).
| Quarter | Tonmya revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $15.0M | +37% | — |
| Q2 2026 | $11.0M | +194% | — |
| Q1 2026 | $3.7M | — | — |
Q3 2026 at a glance
Tonix Pharmaceuticals Holding, Q3 2026: revenue $17.2M (+424% year over year), operating margin -321.6%, net loss $53.3M, operating cash flow −$41.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Tonix Pharmaceuticals Holding's Tonmya revenue?
Tonix Pharmaceuticals Holding's Tonmya revenue was $15.0M in Q3 2026 (third quarter 2026), +37% from Q2 2026.
How has Tonix Pharmaceuticals Holding's Tonmya revenue changed?
Over the last 3 quarters it ranged from $3.7M (Q1 2026) to $15.0M (Q3 2026).
Q3 2026 results → · How Tonix Pharmaceuticals Holding makes money →